176 related articles for article (PubMed ID: 20850913)
1. [Systemic and autoimmune manifestations in myelodysplastic syndromes].
Fain O; Braun T; Stirnemann J; Fenaux P
Rev Med Interne; 2011 Sep; 32(9):552-9. PubMed ID: 20850913
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Saif MW; Hopkins JL; Gore SD
Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
[TBL] [Abstract][Full Text] [Related]
4. [Systemic diseases in myelodysplastic syndromes].
Hebbar M; Hebbar-Savéan K; Fenaux P
Rev Med Interne; 1995; 16(12):897-904. PubMed ID: 8570952
[TBL] [Abstract][Full Text] [Related]
5. [Skin manifestations associated with myelodysplastic syndromes].
Morand JJ; Lightburn E; Richard MA; Hesse-Bonerandi S; Carsuzaa F; Grob JJ
Rev Med Interne; 2001 Sep; 22(9):845-53. PubMed ID: 11599186
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.
Shirota T; Hayashi O; Uchida H; Tonozuka N; Sakai N; Itoh H
Ann Hematol; 1993 Jul; 67(1):45-7. PubMed ID: 8334199
[TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy.
Rosenthal NS; Farhi DC
Am J Clin Pathol; 1996 Nov; 106(5):676-9. PubMed ID: 8929481
[TBL] [Abstract][Full Text] [Related]
8. [Appearance of Sweet's syndrome in a patient with myelodysplastic syndrome (MDS) without relation to the hematological findings of MDS].
Hasegawa Y; Tomiyama J; Ninomiya H; Abe T
Rinsho Ketsueki; 1989 Jun; 30(6):863-7. PubMed ID: 2795896
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?
Braun T; Fenaux P
Best Pract Res Clin Haematol; 2013 Dec; 26(4):327-36. PubMed ID: 24507810
[TBL] [Abstract][Full Text] [Related]
10. Large-vessel arteritis and myelodysplastic syndrome: report of two cases.
Steurer M; Fritsche G; Tzankov A; Gotwald T; Sturm W; Konwalinka G; Gruber J
Eur J Haematol; 2004 Aug; 73(2):128-33. PubMed ID: 15245512
[TBL] [Abstract][Full Text] [Related]
11. A case of erythema nodosum and serositis associated with myelodysplastic syndrome.
Choi JH; Ahn MJ; Park YW; Oh HS; Lee YY; Kim IS
Korean J Intern Med; 2005 Jun; 20(2):177-9. PubMed ID: 16134776
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.
Enright H; Jacob HS; Vercellotti G; Howe R; Belzer M; Miller W
Br J Haematol; 1995 Oct; 91(2):403-8. PubMed ID: 8547082
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune phenomena in patients with myelodysplastic syndromes.
Enright H; Miller W
Leuk Lymphoma; 1997 Feb; 24(5-6):483-9. PubMed ID: 9086438
[TBL] [Abstract][Full Text] [Related]
14. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
15. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
[TBL] [Abstract][Full Text] [Related]
16. Sweet's Syndrome and relapsing polychondritis signal myelodysplastic syndrome.
Diamantino Fda E; Raimundo PM; Fidalgo AI
An Bras Dermatol; 2011; 86(4 Suppl 1):S173-7. PubMed ID: 22068803
[TBL] [Abstract][Full Text] [Related]
17. [Myelodysplastic syndrome with Sweet's syndrome--one case report and literature review].
Zhang F; Lin Y; Li J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):369-70. PubMed ID: 11721436
[TBL] [Abstract][Full Text] [Related]
18. [Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)].
Bouali F; Berrah A; Si Ahmed-Bouali D; Harrieche F; Benhalima M; Hamladji RM; Arrada M
Rev Med Interne; 2005 Oct; 26(10):777-83. PubMed ID: 16203055
[TBL] [Abstract][Full Text] [Related]
19. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
20. [Chromosome abnormalities in myelodysplastic syndrome].
Fujita K; Mori H; Niikura H; Terada H; Shinohara T
Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
